SDMA is an early marker of change in GFR after living-related kidney donation

作者: J. T. Kielstein , H. Veldink , J. Martens-Lobenhoffer , H. Haller , M. Burg

DOI: 10.1093/NDT/GFQ395

关键词:

摘要: * J.T.K. and H.V. contributed equally to the manuscript are both considered first authors. † S.M.B.-B. V.K. last Abstract Background. Early detection of changes in glomerular filtration rate (GFR) is crucial detecting acute kidney injury. There burgeoning evidence from preclinical clinical studies that symmetrical dimethylarginine (SDMA) correlates well with different parameters renal function. In some studies, SDMA even outperformed cre- atinine as a marker GFR. It however unknown how fast increasing after reduction The aim our study was therefore determine temporal change comparison cystatin C defined Methods. Blood samples 24 healthy living-related donors (19 F/5 M), mean age 55.2 ± 8.3 years, were collected prior donation 1, 6, 12, 24, 72 168 h unilateral nephrectomy. levels measured using liquid chromatography-mass spectrometry-based method. Results. Within 6 nephrectomy, i.e. re- duction GFR by 50%, rose 0.571 0.120 0.659 0.135 μmol/L (P < 0.001). Baseline increased 0.87 0.16 1.07 0.15 mg/L Also, serum creatinine sig- nificantly within removal one 65.4 8.4 88.8 10.2 Discussion. might be valuable early experimental set- ting. Future will have clarify whether sensitiv- ity, specificity resolution make it an attractive candidate for assessment func- tion setting.

参考文章(28)
Jens Martens-Lobenhoffer, Stefan Vollmer, Jan T Kielstein, Stefanie M Bode-Böger, L-Arginine, ADMA, SDMA, creatinine, MDRD formula: detour to renal function testing. Journal of Nephrology. ,vol. 21, pp. 959- ,(2008)
Lorenz Risch, Roberto Herklotz, Alfred Blumberg, Andreas R Huber, EFFECTS OF GLUCOCORTICOID IMMUNOSUPPRESSION ON SERUM CYSTATIN C CONCENTRATIONS IN RENAL TRANSPLANT PATIENTS Clinical Chemistry. ,vol. 47, pp. 2055- 2059 ,(2001) , 10.1093/CLINCHEM/47.11.2055
A. Åhlström, M. Tallgren, S. Peltonen, V. Pettilä, Evolution and predictive power of serum cystatin C in acute renal failure. Clinical Nephrology. ,vol. 62, pp. 344- 350 ,(2004) , 10.5414/CNP62344
Teri Manolio, Novel risk markers and clinical practice. The New England Journal of Medicine. ,vol. 349, pp. 1587- 1589 ,(2003) , 10.1056/NEJMP038136
E. Oksenhendler, M. Seligmann, J-P. Clauvel, G. Gorochov, M.F. d'Agay, Brigitte Autran, CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. The Lancet. ,vol. 340, pp. 207- 208 ,(1992) , 10.1016/0140-6736(92)90471-E
Stefan Herget-rosenTHAL, Günter Marggraf, Johannes Hüsing, Frauke Göring, Frank Pietruck, Onno Janssen, Thomas Philipp, Andreas Kribben, Early detection of acute renal failure by serum cystatin C Kidney International. ,vol. 66, pp. 1115- 1122 ,(2004) , 10.1111/J.1523-1755.2004.00861.X
S. Herget-Rosenthal, F. Pietruck, L. Volbracht, T. Philipp, A. Kribben, Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clinical Nephrology. ,vol. 64, pp. 41- 46 ,(2005) , 10.5414/CNP64041
Ovadia Shemesh, Helen Golbetz, Joseph P. Kriss, Bryan D. Myers, Limitations of creatinine as a filtration marker in glomerulopathic patients Kidney International. ,vol. 28, pp. 830- 838 ,(1985) , 10.1038/KI.1985.205
John S Najarian, LE McHugh, AJ Matas, BM Chavers, 20 years or more of follow-up of living kidney donors The Lancet. ,vol. 340, pp. 807- 810 ,(1992) , 10.1016/0140-6736(92)92683-7